Home/Filings/4/0001447348-13-000002
4//SEC Filing

Baker Mark Robert 4

Accession 0001447348-13-000002

CIK 0000835887other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 9:59 AM ET

Size

5.9 KB

Accession

0001447348-13-000002

Insider Transaction Report

Form 4
Period: 2013-01-22
Baker Mark Robert
General Counsel
Transactions
  • Purchase

    Common Stock

    2013-01-22$2.82/sh+900$2,538158,914 total
  • Purchase

    Common Stock

    2013-01-22$2.83/sh+315$891159,229 total
Footnotes (1)
  • [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1
  • filerCIK 0001331438

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 9:59 AM ET
Size
5.9 KB